Medicxi

About

Portfolio · 1

Fore Biotherapeutics

Precision Oncology Treatments

Led ★ 1 round $75.0M committed Latest: 2023-08

Investment activity

Funds · 1

• 5 — $581M Nov 2025

Q&A

What is Medicxi's primary investment focus?

Medicxi is a European investment firm specializing in life sciences, with a focus on drug discovery and the development of therapeutics addressing unmet medical needs.

When was Medicxi founded?

Medicxi was founded in 2016 by the former Index Ventures life sciences team.

Which fund did Medicxi recently close and what was its size?

Medicxi closed Fund 5 in November 2025, raising $581M.

Can you name a notable company in Medicxi's portfolio?

One notable company in Medicxi's portfolio is Fore Biotherapeutics, which focuses on precision oncology treatments.

What was the most recent funding round Medicxi participated in?

Medicxi participated in a Series D round for Fore Biotherapeutics in August 2023, which raised $153.5M.

Who are some of the co-founders of Medicxi?

Some of the co-founders of Medicxi include Richard Lee, Giuseppe Zocco, Kevin Johnson, Francesco De Rubertis, Michele Ollier, Giovanni Pericolini, and David Grainger.

What is Medicxi's geographic focus for its headquarters?

Medicxi's headquarters are located in London, United Kingdom.

What sector does Medicxi primarily invest in?

Medicxi primarily invests in the Health Tech & Life Sciences sector, with one recorded investment round in this area.